Werewolf Therapeutics, Inc. announced the appointment of Meeta Chatterjee, Ph.D., Senior Vice President of Global Business Development at Legend Biotech Corporation, as a member of its board of directors. Chatterjee joins the Werewolf board of directors with more than 30 years of broad strategic and operational experience in pharmaceutical research and development, mergers and acquisition evaluation, in-licensing, and externalization activities. Prior to her current role as the Senior Vice President of Global Business Development at Legend Biotech Corporation, she served as Head of Strategy, Transactions, and Operations within the Business Development and Licensing (BD&L) group at Merck Research Labs.